[
  {"family_id": "F00001", "office": "USPTO", "pub_no": "US10245312B2", "app_no": "14/812,345", "title": "Stable formulation of semaglutide for once-weekly subcutaneous administration", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/26", "A61P3/10"], "cpc": ["A61K38/26", "A61K47/26"], "priority_date": "2014-03-12", "app_date": "2015-07-31", "grant_date": "2019-04-02", "expiry_date": "2035-07-31", "pte_days": 412, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "semaglutide", "claim1_summary_ko": "주 1회 피하 투여를 위한 세마글루타이드 안정화 제형으로, 인산염 완충제와 프로필렌글리콜을 포함한다.", "in_orange_book": true, "ob_use_code": "U-2123", "korean_filing": false},
  {"family_id": "F00001", "office": "EPO", "pub_no": "EP3132798B1", "app_no": "15775421.3", "title": "Stable formulation of semaglutide for once-weekly subcutaneous administration", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2014-03-12", "app_date": "2015-04-10", "grant_date": "2020-01-15", "expiry_date": "2035-04-10", "pte_days": 0, "spc_extension_months": 60, "pediatric_extension": true, "category": "GLP-1RA", "drug_ref": "semaglutide", "claim1_summary_ko": "주 1회 피하 투여를 위한 세마글루타이드 안정화 제형(EU 대응 출원).", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00001", "office": "KIPO", "pub_no": "KR10-2156789B1", "app_no": "10-2016-7028123", "title": "주 1회 피하 투여용 세마글루타이드 안정화 제형", "assignee": "노보 노디스크 에이/에스", "applicant_country": "DK", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2014-03-12", "app_date": "2015-04-10", "grant_date": "2020-08-21", "expiry_date": "2035-04-10", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "semaglutide", "claim1_summary_ko": "주 1회 피하 투여용 세마글루타이드 안정화 제형의 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00001", "office": "JPO", "pub_no": "JP6589123B2", "app_no": "2016-507890", "title": "週1回皮下投与用セマグルチド安定化製剤", "assignee": "ノボノルディスク エー/エス", "applicant_country": "DK", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2014-03-12", "app_date": "2015-04-10", "grant_date": "2019-10-04", "expiry_date": "2035-04-10", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "semaglutide", "claim1_summary_ko": "주 1회 피하 투여용 세마글루타이드 안정화 제형(일본 등록).", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00002", "office": "USPTO", "pub_no": "US11534512B2", "app_no": "16/345,678", "title": "Oral semaglutide tablet with SNAC absorption enhancer", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/26", "A61K9/20"], "cpc": ["A61K38/26", "A61K9/2009"], "priority_date": "2017-08-24", "app_date": "2018-08-23", "grant_date": "2022-12-27", "expiry_date": "2038-08-23", "pte_days": 588, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "oral semaglutide", "claim1_summary_ko": "SNAC 흡수촉진제를 포함하는 경구 세마글루타이드 정제로, 위 점막 흡수율을 5배 이상 증가시킨다.", "in_orange_book": true, "ob_use_code": "U-3145", "korean_filing": true},
  {"family_id": "F00002", "office": "KIPO", "pub_no": "KR10-2451234B1", "app_no": "10-2019-7012345", "title": "SNAC 흡수촉진제를 포함하는 경구 세마글루타이드 정제", "assignee": "노보 노디스크 에이/에스", "applicant_country": "DK", "ipc": ["A61K38/26", "A61K9/20"], "cpc": ["A61K38/26"], "priority_date": "2017-08-24", "app_date": "2018-08-23", "grant_date": "2022-10-15", "expiry_date": "2038-08-23", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "oral semaglutide", "claim1_summary_ko": "SNAC 기반 경구 세마글루타이드 정제의 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00003", "office": "USPTO", "pub_no": "US10987654B1", "app_no": "16/789,012", "title": "Tirzepatide GIP/GLP-1 dual agonist composition", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["A61K38/26", "A61P3/10"], "cpc": ["A61K38/26", "A61K38/22"], "priority_date": "2017-12-21", "app_date": "2018-12-20", "grant_date": "2021-04-27", "expiry_date": "2038-12-20", "pte_days": 245, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "tirzepatide", "claim1_summary_ko": "GIP 및 GLP-1 수용체에 동시 작용하는 39개 아미노산 펩티드(티르제파타이드) 조성물.", "in_orange_book": true, "ob_use_code": "U-2987", "korean_filing": false},
  {"family_id": "F00003", "office": "EPO", "pub_no": "EP3727424B1", "app_no": "18829012.5", "title": "Tirzepatide GIP/GLP-1 dual agonist composition", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2017-12-21", "app_date": "2018-12-20", "grant_date": "2022-09-14", "expiry_date": "2038-12-20", "pte_days": 0, "spc_extension_months": 48, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "tirzepatide", "claim1_summary_ko": "티르제파타이드 EU 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00003", "office": "KIPO", "pub_no": "KR10-2389012B1", "app_no": "10-2020-7019876", "title": "GIP/GLP-1 이중작용제 티르제파타이드 조성물", "assignee": "일라이 릴리 앤드 컴퍼니", "applicant_country": "US", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2017-12-21", "app_date": "2018-12-20", "grant_date": "2022-03-30", "expiry_date": "2038-12-20", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "tirzepatide", "claim1_summary_ko": "티르제파타이드 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00003", "office": "JPO", "pub_no": "JP7012345B2", "app_no": "2020-535124", "title": "GIP/GLP-1二重作動薬チルゼパチド組成物", "assignee": "イーライ リリー アンド カンパニー", "applicant_country": "US", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2017-12-21", "app_date": "2018-12-20", "grant_date": "2022-05-19", "expiry_date": "2038-12-20", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "tirzepatide", "claim1_summary_ko": "티르제파타이드 일본 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00004", "office": "USPTO", "pub_no": "US7407955B2", "app_no": "10/766,113", "title": "Sitagliptin phosphate as DPP-4 inhibitor for type 2 diabetes", "assignee": "Merck Sharp & Dohme Corp.", "applicant_country": "US", "ipc": ["A61K31/4985", "A61P3/10"], "cpc": ["A61K31/4985"], "priority_date": "2003-06-24", "app_date": "2004-01-28", "grant_date": "2008-08-05", "expiry_date": "2024-01-28", "pte_days": 1325, "spc_extension_months": 60, "pediatric_extension": true, "category": "DPP-4i", "drug_ref": "sitagliptin", "claim1_summary_ko": "DPP-4 저해제로 작용하는 시타글립틴 인산염의 제2형 당뇨병 치료용 조성물.", "in_orange_book": true, "ob_use_code": "U-578", "korean_filing": false},
  {"family_id": "F00004", "office": "KIPO", "pub_no": "KR10-0859386B1", "app_no": "10-2005-7024567", "title": "DPP-4 저해제 시타글립틴 인산염", "assignee": "머크 샤프 앤드 돔 코포레이션", "applicant_country": "US", "ipc": ["A61K31/4985"], "cpc": ["A61K31/4985"], "priority_date": "2003-06-24", "app_date": "2004-01-28", "grant_date": "2008-09-18", "expiry_date": "2024-01-28", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DPP-4i", "drug_ref": "sitagliptin", "claim1_summary_ko": "시타글립틴 인산염 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00005", "office": "USPTO", "pub_no": "US6515117B2", "app_no": "09/874,231", "title": "Dapagliflozin SGLT2 inhibitor C-aryl glucoside", "assignee": "Bristol-Myers Squibb Company", "applicant_country": "US", "ipc": ["A61K31/7042", "A61P3/10"], "cpc": ["A61K31/7042"], "priority_date": "2000-06-05", "app_date": "2001-06-04", "grant_date": "2003-02-04", "expiry_date": "2021-06-04", "pte_days": 1097, "spc_extension_months": 60, "pediatric_extension": true, "category": "SGLT2i", "drug_ref": "dapagliflozin", "claim1_summary_ko": "SGLT2 저해제로 작용하는 C-아릴 글루코사이드 화합물(다파글리플로진).", "in_orange_book": true, "ob_use_code": "U-1234", "korean_filing": false},
  {"family_id": "F00005", "office": "EPO", "pub_no": "EP1294714B1", "app_no": "01944215.6", "title": "Dapagliflozin SGLT2 inhibitor C-aryl glucoside", "assignee": "Bristol-Myers Squibb Company", "applicant_country": "US", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2000-06-05", "app_date": "2001-06-04", "grant_date": "2004-11-10", "expiry_date": "2021-06-04", "pte_days": 0, "spc_extension_months": 60, "pediatric_extension": true, "category": "SGLT2i", "drug_ref": "dapagliflozin", "claim1_summary_ko": "다파글리플로진 EU 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00005", "office": "KIPO", "pub_no": "KR10-0728138B1", "app_no": "10-2002-7016789", "title": "SGLT2 저해제 다파글리플로진", "assignee": "브리스톨-마이어스 스퀴브 컴퍼니", "applicant_country": "US", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2000-06-05", "app_date": "2001-06-04", "grant_date": "2007-06-13", "expiry_date": "2021-06-04", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "SGLT2i", "drug_ref": "dapagliflozin", "claim1_summary_ko": "다파글리플로진 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00006", "office": "USPTO", "pub_no": "US7943582B2", "app_no": "11/512,890", "title": "Empagliflozin glucopyranosyl-substituted benzene derivatives", "assignee": "Boehringer Ingelheim Pharma GmbH", "applicant_country": "DE", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2005-09-08", "app_date": "2006-09-08", "grant_date": "2011-05-17", "expiry_date": "2026-09-08", "pte_days": 730, "spc_extension_months": 60, "pediatric_extension": true, "category": "SGLT2i", "drug_ref": "empagliflozin", "claim1_summary_ko": "글루코피라노실 치환 벤젠 유도체로 SGLT2를 선택적으로 저해하는 엠파글리플로진.", "in_orange_book": true, "ob_use_code": "U-1567", "korean_filing": false},
  {"family_id": "F00006", "office": "KIPO", "pub_no": "KR10-1432109B1", "app_no": "10-2008-7008234", "title": "엠파글리플로진 SGLT2 저해제", "assignee": "베링거 인겔하임 파마 게엠베하", "applicant_country": "DE", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2005-09-08", "app_date": "2006-09-08", "grant_date": "2014-08-13", "expiry_date": "2026-09-08", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "SGLT2i", "drug_ref": "empagliflozin", "claim1_summary_ko": "엠파글리플로진 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00007", "office": "USPTO", "pub_no": "US12012345B2", "app_no": "17/234,567", "title": "Orforglipron oral non-peptide GLP-1 receptor agonist", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["A61K31/4439", "A61P3/10"], "cpc": ["A61K31/4439"], "priority_date": "2019-06-15", "app_date": "2020-06-15", "grant_date": "2024-04-23", "expiry_date": "2040-06-15", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "orforglipron", "claim1_summary_ko": "경구 비펩티드 GLP-1 수용체 작용제 오포글립론으로 위장관 단백질 분해에 안정하다.", "in_orange_book": true, "ob_use_code": "U-3456", "korean_filing": false},
  {"family_id": "F00007", "office": "KIPO", "pub_no": "KR10-2598765B1", "app_no": "10-2021-7038234", "title": "경구 비펩티드 GLP-1 수용체 작용제 오포글립론", "assignee": "일라이 릴리 앤드 컴퍼니", "applicant_country": "US", "ipc": ["A61K31/4439"], "cpc": ["A61K31/4439"], "priority_date": "2019-06-15", "app_date": "2020-06-15", "grant_date": "2024-09-12", "expiry_date": "2040-06-15", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "orforglipron", "claim1_summary_ko": "오포글립론 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00008", "office": "USPTO", "pub_no": "US10456789B2", "app_no": "15/678,901", "title": "Continuous glucose monitoring sensor with enzymatic electrode", "assignee": "Dexcom, Inc.", "applicant_country": "US", "ipc": ["A61B5/145", "G01N27/327"], "cpc": ["A61B5/14532"], "priority_date": "2014-11-20", "app_date": "2015-11-19", "grant_date": "2019-10-29", "expiry_date": "2035-11-19", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "CGM", "drug_ref": "Dexcom G6 sensor", "claim1_summary_ko": "효소 전극 기반 연속 혈당 모니터링 센서로 보정 없이 14일 사용 가능.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00008", "office": "KIPO", "pub_no": "KR10-2123456B1", "app_no": "10-2017-7015432", "title": "효소 전극 기반 연속 혈당 모니터링 센서", "assignee": "덱스콤 인코포레이티드", "applicant_country": "US", "ipc": ["A61B5/145"], "cpc": ["A61B5/14532"], "priority_date": "2014-11-20", "app_date": "2015-11-19", "grant_date": "2020-05-08", "expiry_date": "2035-11-19", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "CGM", "drug_ref": "Dexcom G6 sensor", "claim1_summary_ko": "덱스콤 CGM 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00009", "office": "USPTO", "pub_no": "US10912398B2", "app_no": "16/123,890", "title": "FreeStyle Libre flash glucose monitoring with factory calibration", "assignee": "Abbott Diabetes Care Inc.", "applicant_country": "US", "ipc": ["A61B5/145"], "cpc": ["A61B5/14532"], "priority_date": "2015-04-08", "app_date": "2016-04-07", "grant_date": "2021-02-09", "expiry_date": "2036-04-07", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "CGM", "drug_ref": "FreeStyle Libre", "claim1_summary_ko": "공장 보정만으로 동작하는 플래시 글루코스 모니터링 시스템.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00010", "office": "USPTO", "pub_no": "US10987001B2", "app_no": "16/345,012", "title": "MiniMed 780G hybrid closed-loop insulin pump algorithm", "assignee": "Medtronic MiniMed, Inc.", "applicant_country": "US", "ipc": ["A61M5/172", "G06N3/02"], "cpc": ["A61M5/1723"], "priority_date": "2016-08-12", "app_date": "2017-08-11", "grant_date": "2021-04-27", "expiry_date": "2037-08-11", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "closed-loop", "drug_ref": "MiniMed 780G", "claim1_summary_ko": "하이브리드 closed-loop 인슐린 펌프 알고리즘으로 5분 단위 자동 조정과 식후 보정을 수행한다.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00011", "office": "USPTO", "pub_no": "US11567890B2", "app_no": "16/890,123", "title": "Smart insulin pen with Bluetooth dose tracking", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["A61M5/24", "G16H20/17"], "cpc": ["A61M5/24"], "priority_date": "2018-03-14", "app_date": "2019-03-13", "grant_date": "2023-01-31", "expiry_date": "2039-03-13", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "smart pen", "drug_ref": "Tempo Smart Button", "claim1_summary_ko": "Bluetooth로 인슐린 투여량을 자동 기록하는 스마트 인슐린 펜.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00012", "office": "USPTO", "pub_no": "US10456001B2", "app_no": "15/234,890", "title": "Digital therapeutic application for type 2 diabetes lifestyle management", "assignee": "Welldoc, Inc.", "applicant_country": "US", "ipc": ["G16H20/60", "G16H50/20"], "cpc": ["G16H20/60"], "priority_date": "2014-06-18", "app_date": "2015-06-17", "grant_date": "2019-10-22", "expiry_date": "2035-06-17", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DTx", "drug_ref": "BlueStar DTx", "claim1_summary_ko": "제2형 당뇨병 라이프스타일 관리를 위한 디지털 치료제 앱으로 식이·운동·복약 알림 기능 포함.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00012", "office": "KIPO", "pub_no": "KR10-2345678B1", "app_no": "10-2016-7032123", "title": "제2형 당뇨병 라이프스타일 관리 디지털 치료제", "assignee": "웰닥 인코포레이티드", "applicant_country": "US", "ipc": ["G16H20/60"], "cpc": ["G16H20/60"], "priority_date": "2014-06-18", "app_date": "2015-06-17", "grant_date": "2020-12-04", "expiry_date": "2035-06-17", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DTx", "drug_ref": "BlueStar DTx", "claim1_summary_ko": "웰닥 DTx 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00013", "office": "KIPO", "pub_no": "KR10-2456789B1", "app_no": "10-2019-7045678", "title": "GLP-1 수용체 작용제 신규 펩티드 유도체", "assignee": "한미약품 주식회사", "applicant_country": "KR", "ipc": ["A61K38/26", "C07K14/605"], "cpc": ["A61K38/26"], "priority_date": "2018-11-23", "app_date": "2019-11-22", "grant_date": "2023-03-15", "expiry_date": "2039-11-22", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "efpeglenatide", "claim1_summary_ko": "한미약품의 LAPS 기술 기반 주 1회 GLP-1 수용체 작용제 에페글레나타이드.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00013", "office": "USPTO", "pub_no": "US11098456B2", "app_no": "16/678,901", "title": "Novel GLP-1 receptor agonist peptide derivative", "assignee": "Hanmi Pharmaceutical Co., Ltd.", "applicant_country": "KR", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2018-11-23", "app_date": "2019-11-22", "grant_date": "2021-08-24", "expiry_date": "2039-11-22", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "efpeglenatide", "claim1_summary_ko": "한미약품 에페글레나타이드 미국 등록건.", "in_orange_book": true, "ob_use_code": "U-3789", "korean_filing": true},
  {"family_id": "F00013", "office": "EPO", "pub_no": "EP3756677A1", "app_no": "19887654.2", "title": "Novel GLP-1 receptor agonist peptide derivative", "assignee": "Hanmi Pharmaceutical Co., Ltd.", "applicant_country": "KR", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2018-11-23", "app_date": "2019-11-22", "grant_date": null, "expiry_date": "2039-11-22", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "efpeglenatide", "claim1_summary_ko": "한미약품 에페글레나타이드 EU 출원(심사 중).", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00014", "office": "KIPO", "pub_no": "KR10-2512345B1", "app_no": "10-2020-7012345", "title": "DPP-4 저해제 신규 결정형", "assignee": "엘지화학 주식회사", "applicant_country": "KR", "ipc": ["A61K31/4985"], "cpc": ["A61K31/4985"], "priority_date": "2019-04-10", "app_date": "2020-04-09", "grant_date": "2023-08-22", "expiry_date": "2040-04-09", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DPP-4i", "drug_ref": "gemigliptin (LG)", "claim1_summary_ko": "LG화학의 제미글립틴 신규 결정형으로 흡습성을 크게 낮춘 형태.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00015", "office": "KIPO", "pub_no": "KR10-2367890B1", "app_no": "10-2018-7022345", "title": "DPP-4 저해제 에보글립틴 타르타르산염", "assignee": "동아에스티 주식회사", "applicant_country": "KR", "ipc": ["A61K31/4985"], "cpc": ["A61K31/4985"], "priority_date": "2017-08-14", "app_date": "2018-08-13", "grant_date": "2022-02-25", "expiry_date": "2038-08-13", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DPP-4i", "drug_ref": "evogliptin", "claim1_summary_ko": "동아에스티의 에보글립틴 타르타르산염 신규 염 형태.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00016", "office": "KIPO", "pub_no": "KR10-2456012B1", "app_no": "10-2019-7034567", "title": "SGLT2 저해제 신규 전구약물", "assignee": "주식회사 종근당", "applicant_country": "KR", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2018-09-25", "app_date": "2019-09-24", "grant_date": "2023-01-10", "expiry_date": "2039-09-24", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "SGLT2i", "drug_ref": "CKD-SGLT2 prodrug", "claim1_summary_ko": "종근당의 SGLT2 저해제 신규 전구약물로 경구 흡수율을 개선한 형태.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00017", "office": "KIPO", "pub_no": "KR10-2389123B1", "app_no": "10-2018-7045678", "title": "GLP-1 작용제와 SGLT2 저해제 복합 제형", "assignee": "주식회사 대웅제약", "applicant_country": "KR", "ipc": ["A61K38/26", "A61K31/7042"], "cpc": ["A61K38/26"], "priority_date": "2017-12-05", "app_date": "2018-12-04", "grant_date": "2022-06-30", "expiry_date": "2038-12-04", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "combination", "drug_ref": "DWN-12345", "claim1_summary_ko": "대웅제약의 GLP-1RA와 SGLT2i를 결합한 고정용량 복합 제형.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00018", "office": "KIPO", "pub_no": "KR10-2478901B1", "app_no": "10-2020-7056789", "title": "지속형 인슐린 유사체 신규 변이체", "assignee": "주식회사 종근당", "applicant_country": "KR", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2019-07-18", "app_date": "2020-07-17", "grant_date": "2023-11-04", "expiry_date": "2040-07-17", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "CKD-insulin variant", "claim1_summary_ko": "종근당의 지속형 인슐린 유사체 신규 변이체로 주 1회 투여가 가능하다.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00019", "office": "KIPO", "pub_no": "KR10-2598012B1", "app_no": "10-2021-7034567", "title": "AI 기반 인슐린 용량 자동 추천 디지털 치료제", "assignee": "에이치케이이노엔 주식회사", "applicant_country": "KR", "ipc": ["G16H20/17", "G16H50/20"], "cpc": ["G16H20/17"], "priority_date": "2020-05-22", "app_date": "2021-05-21", "grant_date": "2024-02-14", "expiry_date": "2041-05-21", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DTx", "drug_ref": "HK-DTx-001", "claim1_summary_ko": "HK inno.N의 AI 기반 인슐린 용량 자동 추천 디지털 치료제로 CGM 데이터를 입력으로 사용한다.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00020", "office": "KIPO", "pub_no": "KR10-2456234B1", "app_no": "10-2019-7067890", "title": "트레시바 바이오시밀러 인슐린 데글루덱 제형", "assignee": "주식회사 셀트리온", "applicant_country": "KR", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2018-10-30", "app_date": "2019-10-29", "grant_date": "2023-04-19", "expiry_date": "2039-10-29", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin degludec biosimilar", "claim1_summary_ko": "셀트리온의 인슐린 데글루덱 바이오시밀러 제형.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00021", "office": "KIPO", "pub_no": "KR10-2389456B1", "app_no": "10-2018-7078901", "title": "란투스 바이오시밀러 인슐린 글라진 고농도 제형", "assignee": "삼성바이오에피스 주식회사", "applicant_country": "KR", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2017-06-15", "app_date": "2018-06-14", "grant_date": "2022-09-08", "expiry_date": "2038-06-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin glargine U300 biosimilar", "claim1_summary_ko": "삼성바이오에피스의 인슐린 글라진 U300 바이오시밀러 고농도 제형.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00022", "office": "KIPO", "pub_no": "KR10-2367123B1", "app_no": "10-2017-7089012", "title": "당뇨망막병증 진단 보조 AI 영상 분석 알고리즘", "assignee": "주식회사 일동제약", "applicant_country": "KR", "ipc": ["G16H50/20", "G06N3/08"], "cpc": ["G16H50/20"], "priority_date": "2016-09-12", "app_date": "2017-09-11", "grant_date": "2022-01-18", "expiry_date": "2037-09-11", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DTx", "drug_ref": "Ildong-DRetinopathy-AI", "claim1_summary_ko": "일동제약의 당뇨망막병증 진단 보조 AI 영상 분석 알고리즘.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00023", "office": "KIPO", "pub_no": "KR10-2412345B1", "app_no": "10-2018-7098901", "title": "당뇨병 예방용 천연물 유래 화합물", "assignee": "녹십자홀딩스 주식회사", "applicant_country": "KR", "ipc": ["A61K36/00", "A61P3/10"], "cpc": ["A61K36/00"], "priority_date": "2017-04-20", "app_date": "2018-04-19", "grant_date": "2022-07-22", "expiry_date": "2038-04-19", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "natural", "drug_ref": "GC-DM-extract", "claim1_summary_ko": "녹십자의 당뇨병 예방용 천연물 유래 화합물 추출물.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00024", "office": "KIPO", "pub_no": "KR10-2543210B1", "app_no": "10-2020-7123456", "title": "GLP-1/GIP/글루카곤 삼중 작용제", "assignee": "에스케이바이오팜 주식회사", "applicant_country": "KR", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2019-08-30", "app_date": "2020-08-29", "grant_date": "2024-01-25", "expiry_date": "2040-08-29", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "SK-tri-agonist", "claim1_summary_ko": "SK바이오팜의 GLP-1/GIP/글루카곤 삼중 작용제 신규 펩티드.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00025", "office": "EPO", "pub_no": "EP2925748B1", "app_no": "13860123.4", "title": "Insulin glargine high-strength U300 formulation", "assignee": "Sanofi-Aventis Deutschland GmbH", "applicant_country": "DE", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2012-11-29", "app_date": "2013-11-28", "grant_date": "2017-08-30", "expiry_date": "2033-11-28", "pte_days": 0, "spc_extension_months": 60, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin glargine U300", "claim1_summary_ko": "Sanofi의 인슐린 글라진 U300 고농도 제형(Toujeo).", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00025", "office": "USPTO", "pub_no": "US9603897B2", "app_no": "14/091,234", "title": "Insulin glargine high-strength U300 formulation", "assignee": "Sanofi-Aventis U.S. LLC", "applicant_country": "DE", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2012-11-29", "app_date": "2013-11-28", "grant_date": "2017-03-28", "expiry_date": "2033-11-28", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin glargine U300", "claim1_summary_ko": "Toujeo 미국 등록건.", "in_orange_book": true, "ob_use_code": "U-2456", "korean_filing": false},
  {"family_id": "F00026", "office": "USPTO", "pub_no": "US8889666B2", "app_no": "12/567,890", "title": "Insulin degludec ultra-long-acting basal insulin", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2008-09-12", "app_date": "2009-09-11", "grant_date": "2014-11-18", "expiry_date": "2029-09-11", "pte_days": 0, "spc_extension_months": 60, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin degludec", "claim1_summary_ko": "Tresiba 인슐린 데글루덱 초장시간 작용 기저 인슐린.", "in_orange_book": true, "ob_use_code": "U-1789", "korean_filing": false},
  {"family_id": "F00027", "office": "USPTO", "pub_no": "US8669227B2", "app_no": "12/890,123", "title": "Canagliflozin SGLT2 inhibitor crystalline form", "assignee": "Janssen Pharmaceutica NV", "applicant_country": "BE", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2009-07-10", "app_date": "2010-07-09", "grant_date": "2014-03-11", "expiry_date": "2030-07-09", "pte_days": 1067, "spc_extension_months": 60, "pediatric_extension": false, "category": "SGLT2i", "drug_ref": "canagliflozin", "claim1_summary_ko": "카나글리플로진의 안정한 결정형으로 SGLT2를 선택적으로 저해.", "in_orange_book": true, "ob_use_code": "U-1456", "korean_filing": false},
  {"family_id": "F00028", "office": "USPTO", "pub_no": "US8268791B2", "app_no": "12/345,678", "title": "Linagliptin DPP-4 inhibitor xanthine derivative", "assignee": "Boehringer Ingelheim Pharma GmbH", "applicant_country": "DE", "ipc": ["A61K31/522", "A61K31/4985"], "cpc": ["A61K31/522"], "priority_date": "2007-08-17", "app_date": "2008-08-16", "grant_date": "2012-09-18", "expiry_date": "2028-08-16", "pte_days": 837, "spc_extension_months": 60, "pediatric_extension": false, "category": "DPP-4i", "drug_ref": "linagliptin", "claim1_summary_ko": "리나글립틴 잔틴 유도체 DPP-4 저해제(Tradjenta).", "in_orange_book": true, "ob_use_code": "U-1234", "korean_filing": false},
  {"family_id": "F00029", "office": "USPTO", "pub_no": "US8101626B2", "app_no": "11/234,567", "title": "Saxagliptin DPP-4 inhibitor", "assignee": "Bristol-Myers Squibb Company", "applicant_country": "US", "ipc": ["A61K31/4985"], "cpc": ["A61K31/4985"], "priority_date": "2005-02-18", "app_date": "2006-02-17", "grant_date": "2012-01-24", "expiry_date": "2026-02-17", "pte_days": 1283, "spc_extension_months": 60, "pediatric_extension": false, "category": "DPP-4i", "drug_ref": "saxagliptin", "claim1_summary_ko": "삭사글립틴 DPP-4 저해제(Onglyza).", "in_orange_book": true, "ob_use_code": "U-1098", "korean_filing": false},
  {"family_id": "F00030", "office": "USPTO", "pub_no": "US7973056B2", "app_no": "11/789,012", "title": "Alogliptin DPP-4 inhibitor benzonitrile", "assignee": "Takeda Pharmaceutical Co., Ltd.", "applicant_country": "JP", "ipc": ["A61K31/4985"], "cpc": ["A61K31/4985"], "priority_date": "2006-03-24", "app_date": "2007-03-23", "grant_date": "2011-07-05", "expiry_date": "2027-03-23", "pte_days": 569, "spc_extension_months": 60, "pediatric_extension": false, "category": "DPP-4i", "drug_ref": "alogliptin", "claim1_summary_ko": "알로글립틴 벤조니트릴 DPP-4 저해제(Nesina).", "in_orange_book": true, "ob_use_code": "U-1345", "korean_filing": false},
  {"family_id": "F00031", "office": "USPTO", "pub_no": "US7674913B2", "app_no": "11/123,890", "title": "Liraglutide GLP-1 analogue with fatty acid acylation", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "1996-05-07", "app_date": "2005-09-01", "grant_date": "2010-03-09", "expiry_date": "2025-09-01", "pte_days": 1043, "spc_extension_months": 60, "pediatric_extension": true, "category": "GLP-1RA", "drug_ref": "liraglutide", "claim1_summary_ko": "Liraglutide 지방산 아실화 GLP-1 유사체(Victoza/Saxenda).", "in_orange_book": true, "ob_use_code": "U-1567", "korean_filing": false},
  {"family_id": "F00032", "office": "USPTO", "pub_no": "US7297761B2", "app_no": "10/890,234", "title": "Exenatide synthetic exendin-4 GLP-1 mimetic", "assignee": "Amylin Pharmaceuticals, LLC", "applicant_country": "US", "ipc": ["A61K38/22"], "cpc": ["A61K38/22"], "priority_date": "1998-08-06", "app_date": "2004-07-13", "grant_date": "2007-11-20", "expiry_date": "2024-07-13", "pte_days": 1234, "spc_extension_months": 60, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "exenatide", "claim1_summary_ko": "Exenatide 합성 exendin-4 GLP-1 모방체(Byetta).", "in_orange_book": true, "ob_use_code": "U-790", "korean_filing": false},
  {"family_id": "F00033", "office": "USPTO", "pub_no": "US8951973B2", "app_no": "13/234,567", "title": "Dulaglutide GLP-1 Fc fusion protein", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["C07K14/605", "A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2005-12-09", "app_date": "2011-09-15", "grant_date": "2015-02-10", "expiry_date": "2031-09-15", "pte_days": 723, "spc_extension_months": 60, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "dulaglutide", "claim1_summary_ko": "Dulaglutide GLP-1 Fc 융합 단백질(Trulicity).", "in_orange_book": true, "ob_use_code": "U-1789", "korean_filing": false},
  {"family_id": "F00034", "office": "USPTO", "pub_no": "US8729031B2", "app_no": "13/567,890", "title": "Insulin glargine U100 once-daily basal insulin", "assignee": "Sanofi-Aventis U.S. LLC", "applicant_country": "DE", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "1994-12-22", "app_date": "2012-08-06", "grant_date": "2014-05-20", "expiry_date": "2014-08-12", "pte_days": 0, "spc_extension_months": 60, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin glargine U100", "claim1_summary_ko": "Insulin glargine U100 1일 1회 기저 인슐린(Lantus).", "in_orange_book": true, "ob_use_code": "U-401", "korean_filing": false},
  {"family_id": "F00035", "office": "USPTO", "pub_no": "US7572788B2", "app_no": "10/567,234", "title": "Pioglitazone TZD insulin sensitizer extended release", "assignee": "Takeda Pharmaceutical Co., Ltd.", "applicant_country": "JP", "ipc": ["A61K31/4439"], "cpc": ["A61K31/4439"], "priority_date": "2001-05-21", "app_date": "2005-08-09", "grant_date": "2009-08-11", "expiry_date": "2025-08-09", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "TZD", "drug_ref": "pioglitazone XR", "claim1_summary_ko": "Pioglitazone TZD 인슐린 민감화제 서방형(Actos XR).", "in_orange_book": true, "ob_use_code": "U-1234", "korean_filing": false},
  {"family_id": "F00036", "office": "USPTO", "pub_no": "US6034090A", "app_no": "08/567,123", "title": "Metformin extended release dosage form", "assignee": "Bristol-Myers Squibb Company", "applicant_country": "US", "ipc": ["A61K31/155"], "cpc": ["A61K31/155"], "priority_date": "1995-12-22", "app_date": "1997-12-22", "grant_date": "2000-03-07", "expiry_date": "2017-12-22", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "biguanide", "drug_ref": "metformin XR", "claim1_summary_ko": "Metformin 서방형 제형(Glucophage XR) — 만료됨, generic 진입 완료.", "in_orange_book": true, "ob_use_code": "U-345", "korean_filing": false},
  {"family_id": "F00037", "office": "EPO", "pub_no": "EP2925761B1", "app_no": "13860456.7", "title": "Tresiba degludec/aspart dual insulin combination", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2012-12-03", "app_date": "2013-12-02", "grant_date": "2018-04-25", "expiry_date": "2033-12-02", "pte_days": 0, "spc_extension_months": 60, "pediatric_extension": false, "category": "insulin", "drug_ref": "degludec/aspart", "claim1_summary_ko": "Ryzodeg 데글루덱/아스파트 이중 인슐린 복합제형.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00038", "office": "EPO", "pub_no": "EP2986317B1", "app_no": "14790234.1", "title": "Toujeo Max SoloStar prefilled insulin pen delivery device", "assignee": "Sanofi-Aventis Deutschland GmbH", "applicant_country": "DE", "ipc": ["A61M5/24"], "cpc": ["A61M5/24"], "priority_date": "2013-04-22", "app_date": "2014-04-21", "grant_date": "2018-09-12", "expiry_date": "2034-04-21", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "smart pen", "drug_ref": "Toujeo Max SoloStar", "claim1_summary_ko": "Toujeo Max SoloStar 사전 충진 인슐린 펜 디바이스.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00039", "office": "JPO", "pub_no": "JP6234567B2", "app_no": "2014-512345", "title": "テネリグリプチン水和物 DPP-4 阻害剤", "assignee": "田辺三菱製薬株式会社", "applicant_country": "JP", "ipc": ["A61K31/4985"], "cpc": ["A61K31/4985"], "priority_date": "2012-03-15", "app_date": "2013-03-14", "grant_date": "2017-11-10", "expiry_date": "2033-03-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DPP-4i", "drug_ref": "teneligliptin", "claim1_summary_ko": "Teneligliptin 수화물 DPP-4 저해제(Tenelia, 일본).", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00040", "office": "JPO", "pub_no": "JP6345678B2", "app_no": "2015-623456", "title": "トホグリフロジン水和物 SGLT2 阻害剤", "assignee": "中外製薬株式会社", "applicant_country": "JP", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2013-06-20", "app_date": "2014-06-19", "grant_date": "2018-03-23", "expiry_date": "2034-06-19", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "SGLT2i", "drug_ref": "tofogliflozin", "claim1_summary_ko": "Tofogliflozin 수화물 SGLT2 저해제(Apleway/Deberza).", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00041", "office": "JPO", "pub_no": "JP6456789B2", "app_no": "2016-712345", "title": "イプラグリフロジン L-プロリン SGLT2 阻害剤", "assignee": "アステラス製薬株式会社", "applicant_country": "JP", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2014-09-08", "app_date": "2015-09-07", "grant_date": "2019-02-14", "expiry_date": "2035-09-07", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "SGLT2i", "drug_ref": "ipragliflozin", "claim1_summary_ko": "Ipragliflozin L-프롤린 SGLT2 저해제(Suglat).", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00042", "office": "CNIPA", "pub_no": "CN104788429B", "app_no": "201510234567.8", "title": "新型GLP-1受体激动剂多肽及其制备方法", "assignee": "深圳信立泰药业股份有限公司", "applicant_country": "CN", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2014-05-10", "app_date": "2015-05-09", "grant_date": "2018-08-17", "expiry_date": "2035-05-09", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "XLT-GLP1", "claim1_summary_ko": "Shenzhen Salubris의 신규 GLP-1 수용체 작용제 펩티드.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00043", "office": "CNIPA", "pub_no": "CN105669801B", "app_no": "201610345678.9", "title": "SGLT2抑制剂新晶型及其药物组合物", "assignee": "豪森药业集团有限公司", "applicant_country": "CN", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2015-06-15", "app_date": "2016-06-14", "grant_date": "2019-04-26", "expiry_date": "2036-06-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "SGLT2i", "drug_ref": "Hansoh-SGLT2", "claim1_summary_ko": "Hansoh의 SGLT2 저해제 신규 결정형.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00044", "office": "CNIPA", "pub_no": "CN106692034B", "app_no": "201710456789.0", "title": "口服胰岛素纳米载体制剂", "assignee": "复旦大学", "applicant_country": "CN", "ipc": ["A61K38/28", "A61K9/51"], "cpc": ["A61K38/28"], "priority_date": "2016-11-20", "app_date": "2017-11-19", "grant_date": "2020-09-08", "expiry_date": "2037-11-19", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "oral insulin nano-carrier", "claim1_summary_ko": "Fudan University의 경구 인슐린 나노 담체 제형.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00045", "office": "CNIPA", "pub_no": "CN108456789B", "app_no": "201810567890.1", "title": "连续血糖监测传感器及其制造方法", "assignee": "北京怡成生物电子技术股份有限公司", "applicant_country": "CN", "ipc": ["A61B5/145"], "cpc": ["A61B5/14532"], "priority_date": "2017-08-15", "app_date": "2018-08-14", "grant_date": "2021-12-03", "expiry_date": "2038-08-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "CGM", "drug_ref": "Yicheng CGM", "claim1_summary_ko": "Yicheng Bioelectronic의 연속 혈당 모니터링 센서.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00046", "office": "WIPO", "pub_no": "WO2020/123456A1", "app_no": "PCT/EP2019/078901", "title": "Novel oral GLP-1 receptor agonist small molecule", "assignee": "Pfizer Inc.", "applicant_country": "US", "ipc": ["A61K31/4439"], "cpc": ["A61K31/4439"], "priority_date": "2018-12-15", "app_date": "2019-10-25", "grant_date": null, "expiry_date": "2039-10-25", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "danuglipron", "claim1_summary_ko": "Pfizer의 경구 GLP-1 수용체 작용제 소분자 다누글립론.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00047", "office": "WIPO", "pub_no": "WO2021/234567A1", "app_no": "PCT/US2020/123456", "title": "GLP-1/GIP/glucagon triple agonist peptide", "assignee": "Hanmi Pharmaceutical Co., Ltd.", "applicant_country": "KR", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2019-05-12", "app_date": "2020-05-11", "grant_date": null, "expiry_date": "2040-05-11", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "HM15211", "claim1_summary_ko": "한미약품 HM15211 GLP-1/GIP/글루카곤 삼중 작용제 PCT 출원.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00048", "office": "WIPO", "pub_no": "WO2022/345678A1", "app_no": "PCT/EP2021/234567", "title": "Long-acting insulin once-weekly basal insulin analog", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2020-06-08", "app_date": "2021-06-07", "grant_date": null, "expiry_date": "2041-06-07", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin icodec", "claim1_summary_ko": "Novo Nordisk의 인슐린 이코덱 주 1회 기저 인슐린 유사체.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00048", "office": "USPTO", "pub_no": "US11789012B2", "app_no": "17/345,678", "title": "Long-acting insulin once-weekly basal insulin analog", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2020-06-08", "app_date": "2021-06-07", "grant_date": "2023-10-17", "expiry_date": "2041-06-07", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin icodec", "claim1_summary_ko": "Insulin icodec 미국 등록건.", "in_orange_book": true, "ob_use_code": "U-3567", "korean_filing": false},
  {"family_id": "F00048", "office": "KIPO", "pub_no": "KR10-2612345B1", "app_no": "10-2022-7012345", "title": "주 1회 투여 기저 인슐린 유사체 이코덱", "assignee": "노보 노디스크 에이/에스", "applicant_country": "DK", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2020-06-08", "app_date": "2021-06-07", "grant_date": "2024-05-30", "expiry_date": "2041-06-07", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin icodec", "claim1_summary_ko": "Insulin icodec 한국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00049", "office": "USPTO", "pub_no": "US10456234B2", "app_no": "15/890,234", "title": "Omnipod tubeless insulin pump disposable patch", "assignee": "Insulet Corporation", "applicant_country": "US", "ipc": ["A61M5/142"], "cpc": ["A61M5/14248"], "priority_date": "2015-02-10", "app_date": "2016-02-09", "grant_date": "2019-10-29", "expiry_date": "2036-02-09", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin pump", "drug_ref": "Omnipod 5", "claim1_summary_ko": "Insulet Omnipod 튜브 없는 일회용 인슐린 패치 펌프.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00050", "office": "USPTO", "pub_no": "US11234567B2", "app_no": "16/567,234", "title": "T-slim X2 insulin pump Control-IQ algorithm", "assignee": "Tandem Diabetes Care, Inc.", "applicant_country": "US", "ipc": ["A61M5/172"], "cpc": ["A61M5/1723"], "priority_date": "2017-06-20", "app_date": "2018-06-19", "grant_date": "2022-02-01", "expiry_date": "2038-06-19", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "closed-loop", "drug_ref": "Tandem t:slim X2 Control-IQ", "claim1_summary_ko": "Tandem t:slim X2 Control-IQ 예측적 저혈당 차단 알고리즘.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00051", "office": "EPO", "pub_no": "EP3756789A1", "app_no": "19234567.8", "title": "Bigfoot Unity smart insulin pen cap with dose recommendations", "assignee": "Bigfoot Biomedical, Inc.", "applicant_country": "US", "ipc": ["A61M5/24", "G16H20/17"], "cpc": ["A61M5/24"], "priority_date": "2018-05-25", "app_date": "2019-05-24", "grant_date": null, "expiry_date": "2039-05-24", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "smart pen", "drug_ref": "Bigfoot Unity", "claim1_summary_ko": "Bigfoot Unity 인슐린 펜 캡, CGM 데이터 기반 용량 권장.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00052", "office": "USPTO", "pub_no": "US10987234B2", "app_no": "16/234,890", "title": "Glucose-responsive insulin delivery hydrogel", "assignee": "Massachusetts Institute of Technology", "applicant_country": "US", "ipc": ["A61K38/28", "A61K9/00"], "cpc": ["A61K38/28"], "priority_date": "2016-12-18", "app_date": "2017-12-17", "grant_date": "2021-04-27", "expiry_date": "2037-12-17", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "MIT glucose-responsive hydrogel", "claim1_summary_ko": "MIT의 혈당 반응성 인슐린 방출 하이드로젤 시스템.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00053", "office": "USPTO", "pub_no": "US11567345B2", "app_no": "16/789,234", "title": "Pramlintide amylin analog for postprandial glucose control", "assignee": "AstraZeneca AB", "applicant_country": "GB", "ipc": ["A61K38/22"], "cpc": ["A61K38/22"], "priority_date": "2018-07-22", "app_date": "2019-07-21", "grant_date": "2023-01-31", "expiry_date": "2039-07-21", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "amylin", "drug_ref": "pramlintide formulation", "claim1_summary_ko": "프람린타이드 아밀린 유사체의 식후 혈당 조절용 개선 제형.", "in_orange_book": true, "ob_use_code": "U-1234", "korean_filing": false},
  {"family_id": "F00054", "office": "KIPO", "pub_no": "KR10-2412345A", "app_no": "10-2022-7045678", "title": "AI 기반 폐쇄 루프 인슐린 펌프 알고리즘", "assignee": "주식회사 삼성바이오에피스", "applicant_country": "KR", "ipc": ["A61M5/172", "G06N3/08"], "cpc": ["A61M5/1723"], "priority_date": "2021-09-15", "app_date": "2022-09-14", "grant_date": null, "expiry_date": "2042-09-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "closed-loop", "drug_ref": "SBE-closed-loop", "claim1_summary_ko": "삼성바이오에피스의 AI 기반 closed-loop 인슐린 펌프 알고리즘(공개).", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00055", "office": "USPTO", "pub_no": "US12089012B2", "app_no": "17/890,123", "title": "Retatrutide GIP/GLP-1/glucagon triple agonist", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2020-04-15", "app_date": "2021-04-14", "grant_date": "2024-08-13", "expiry_date": "2041-04-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "retatrutide", "claim1_summary_ko": "Eli Lilly의 GIP/GLP-1/글루카곤 삼중 작용제 레타트루타이드.", "in_orange_book": true, "ob_use_code": "U-3890", "korean_filing": false},
  {"family_id": "F00056", "office": "KIPO", "pub_no": "KR10-2523456B1", "app_no": "10-2020-7089012", "title": "당뇨병성 신경병증 치료용 신규 화합물", "assignee": "주식회사 동아에스티", "applicant_country": "KR", "ipc": ["A61K31/4439", "A61P3/10"], "cpc": ["A61K31/4439"], "priority_date": "2019-12-10", "app_date": "2020-12-09", "grant_date": "2023-09-26", "expiry_date": "2040-12-09", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "complication", "drug_ref": "DA-9801", "claim1_summary_ko": "동아에스티 DA-9801 당뇨병성 신경병증 치료용 신규 화합물.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00057", "office": "USPTO", "pub_no": "US7196066B1", "app_no": "10/123,456", "title": "Glargine recombinant insulin analog A21Gly", "assignee": "Sanofi-Aventis Deutschland GmbH", "applicant_country": "DE", "ipc": ["C07K14/62"], "cpc": ["C07K14/62"], "priority_date": "1994-12-22", "app_date": "2002-04-15", "grant_date": "2007-03-27", "expiry_date": "2014-12-22", "pte_days": 1234, "spc_extension_months": 60, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin glargine", "claim1_summary_ko": "Sanofi의 인슐린 글라진 재조합 A21Gly 유사체 핵심 특허 — 만료.", "in_orange_book": true, "ob_use_code": "U-198", "korean_filing": false},
  {"family_id": "F00058", "office": "USPTO", "pub_no": "US9931309B2", "app_no": "14/567,890", "title": "Insulin aspart fast-acting analog formulation", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2013-12-16", "app_date": "2014-12-15", "grant_date": "2018-04-03", "expiry_date": "2034-12-15", "pte_days": 0, "spc_extension_months": 60, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin aspart (Fiasp)", "claim1_summary_ko": "Fiasp 초속효성 인슐린 아스파트 제형(니코틴아마이드 추가).", "in_orange_book": true, "ob_use_code": "U-2123", "korean_filing": false},
  {"family_id": "F00059", "office": "USPTO", "pub_no": "US10987456B2", "app_no": "16/234,123", "title": "Lyumjev ultra-rapid lispro insulin formulation", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2016-11-04", "app_date": "2017-11-03", "grant_date": "2021-04-27", "expiry_date": "2037-11-03", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin lispro (Lyumjev)", "claim1_summary_ko": "Lyumjev 초속효성 인슐린 리스프로 제형(트레프로스티닐, 시트레이트 추가).", "in_orange_book": true, "ob_use_code": "U-2456", "korean_filing": false},
  {"family_id": "F00060", "office": "USPTO", "pub_no": "US11567890B1", "app_no": "17/123,890", "title": "Bertaglifozin SGLT2 inhibitor C-glucoside derivative", "assignee": "Merck Sharp & Dohme LLC", "applicant_country": "US", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2019-03-20", "app_date": "2020-03-19", "grant_date": "2023-01-31", "expiry_date": "2040-03-19", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "SGLT2i", "drug_ref": "bexagliflozin", "claim1_summary_ko": "Bexagliflozin SGLT2 저해제 C-글루코사이드 유도체.", "in_orange_book": true, "ob_use_code": "U-3789", "korean_filing": false},
  {"family_id": "F00061", "office": "KIPO", "pub_no": "KR10-2589012B1", "app_no": "10-2021-7067890", "title": "1형 당뇨병 면역치료용 항-CD3 항체", "assignee": "주식회사 LG화학", "applicant_country": "KR", "ipc": ["C07K16/28", "A61P3/10"], "cpc": ["C07K16/2809"], "priority_date": "2020-08-25", "app_date": "2021-08-24", "grant_date": "2024-03-19", "expiry_date": "2041-08-24", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "T1D-immune", "drug_ref": "LG anti-CD3", "claim1_summary_ko": "LG화학의 1형 당뇨병 면역치료용 항-CD3 단클론항체(테플리주맙 후보).", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00062", "office": "USPTO", "pub_no": "US11234890B2", "app_no": "16/890,567", "title": "Teplizumab anti-CD3 antibody for delaying type 1 diabetes onset", "assignee": "Provention Bio, Inc.", "applicant_country": "US", "ipc": ["C07K16/28"], "cpc": ["C07K16/2809"], "priority_date": "2017-10-15", "app_date": "2018-10-14", "grant_date": "2022-02-01", "expiry_date": "2038-10-14", "pte_days": 412, "spc_extension_months": 0, "pediatric_extension": true, "category": "T1D-immune", "drug_ref": "teplizumab", "claim1_summary_ko": "Teplizumab 항-CD3 단클론항체로 1형 당뇨병 발병을 지연시키는 용도.", "in_orange_book": true, "ob_use_code": "U-3567", "korean_filing": false},
  {"family_id": "F00063", "office": "USPTO", "pub_no": "US10567234B2", "app_no": "15/345,234", "title": "Diabetes Prevention Program digital coaching platform", "assignee": "Omada Health, Inc.", "applicant_country": "US", "ipc": ["G16H20/70", "G16H50/20"], "cpc": ["G16H20/70"], "priority_date": "2014-09-25", "app_date": "2015-09-24", "grant_date": "2020-02-18", "expiry_date": "2035-09-24", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DTx", "drug_ref": "Omada Health DPP", "claim1_summary_ko": "Omada Health의 당뇨병 예방 프로그램 디지털 코칭 플랫폼.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00064", "office": "USPTO", "pub_no": "US11089012B2", "app_no": "16/678,234", "title": "Livongo connected glucose meter with real-time coaching", "assignee": "Livongo Health, Inc.", "applicant_country": "US", "ipc": ["G16H20/60", "A61B5/145"], "cpc": ["G16H20/60"], "priority_date": "2017-11-30", "app_date": "2018-11-29", "grant_date": "2021-08-17", "expiry_date": "2038-11-29", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DTx", "drug_ref": "Livongo for Diabetes", "claim1_summary_ko": "Livongo의 실시간 코칭 기능 연결형 혈당 측정기.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00065", "office": "USPTO", "pub_no": "US12100123B2", "app_no": "17/789,234", "title": "Survodutide GLP-1/glucagon dual agonist for obesity and diabetes", "assignee": "Boehringer Ingelheim International GmbH", "applicant_country": "DE", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2020-10-20", "app_date": "2021-10-19", "grant_date": "2024-09-24", "expiry_date": "2041-10-19", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "survodutide", "claim1_summary_ko": "Boehringer Ingelheim/Zealand의 서보두타이드 GLP-1/글루카곤 이중 작용제.", "in_orange_book": true, "ob_use_code": "U-3890", "korean_filing": false},
  {"family_id": "F00066", "office": "USPTO", "pub_no": "US11890234B2", "app_no": "17/234,890", "title": "Mazdutide GLP-1/glucagon dual agonist (LY3305677)", "assignee": "Innovent Biologics, Inc.", "applicant_country": "CN", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2019-11-15", "app_date": "2020-11-14", "grant_date": "2024-02-13", "expiry_date": "2040-11-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "mazdutide", "claim1_summary_ko": "Innovent의 마즈두타이드(LY3305677) GLP-1/글루카곤 이중 작용제.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00066", "office": "CNIPA", "pub_no": "CN112789123B", "app_no": "201911234567.8", "title": "GLP-1/glucagon双重激动剂多肽(玛仕度肽)", "assignee": "信达生物制药(苏州)有限公司", "applicant_country": "CN", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2019-11-15", "app_date": "2020-11-14", "grant_date": "2023-08-22", "expiry_date": "2040-11-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "mazdutide", "claim1_summary_ko": "Innovent 마즈두타이드 중국 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00067", "office": "USPTO", "pub_no": "US12345678B2", "app_no": "18/123,456", "title": "Cagrilintide amylin analog co-administered with semaglutide (CagriSema)", "assignee": "Novo Nordisk A/S", "applicant_country": "DK", "ipc": ["A61K38/22"], "cpc": ["A61K38/22"], "priority_date": "2021-04-22", "app_date": "2022-04-21", "grant_date": "2025-03-18", "expiry_date": "2042-04-21", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "amylin", "drug_ref": "cagrilintide/semaglutide (CagriSema)", "claim1_summary_ko": "Novo Nordisk CagriSema — 카그릴린타이드 아밀린 유사체와 세마글루타이드 병용.", "in_orange_book": true, "ob_use_code": "U-4012", "korean_filing": false},
  {"family_id": "F00068", "office": "WIPO", "pub_no": "WO2023/456789A1", "app_no": "PCT/KR2022/012345", "title": "신규 GLP-1/GIP/글루카곤 삼중 작용제 펩티드 및 그 용도", "assignee": "주식회사 한미약품", "applicant_country": "KR", "ipc": ["A61K38/26"], "cpc": ["A61K38/26"], "priority_date": "2021-09-30", "app_date": "2022-09-29", "grant_date": null, "expiry_date": "2042-09-29", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "HM15275", "claim1_summary_ko": "한미약품 HM15275 GLP-1/GIP/글루카곤 삼중 작용제 PCT 출원.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00069", "office": "KIPO", "pub_no": "KR10-2645123A", "app_no": "10-2023-7012345", "title": "차세대 closed-loop 인공췌장 시스템 한국 등록", "assignee": "주식회사 SK바이오팜", "applicant_country": "KR", "ipc": ["A61M5/172", "G16H20/17"], "cpc": ["A61M5/1723"], "priority_date": "2022-06-10", "app_date": "2023-06-09", "grant_date": null, "expiry_date": "2043-06-09", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "closed-loop", "drug_ref": "SK-pancreas-AI", "claim1_summary_ko": "SK바이오팜의 차세대 closed-loop 인공췌장 시스템 한국 출원(심사 중).", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00070", "office": "KIPO", "pub_no": "KR10-2667890B1", "app_no": "10-2022-7089012", "title": "당뇨병성 신장질환 치료용 SGLT2/SGLT1 이중 저해제", "assignee": "주식회사 종근당", "applicant_country": "KR", "ipc": ["A61K31/7042"], "cpc": ["A61K31/7042"], "priority_date": "2021-11-25", "app_date": "2022-11-24", "grant_date": "2024-12-10", "expiry_date": "2042-11-24", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "SGLT2i", "drug_ref": "CKD-dual-SGLT", "claim1_summary_ko": "종근당의 SGLT2/SGLT1 이중 저해제 당뇨병성 신장질환 치료용.", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00071", "office": "EPO", "pub_no": "EP4012345A1", "app_no": "20890123.4", "title": "Once-weekly basal insulin Fc fusion analog", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2019-12-22", "app_date": "2020-12-21", "grant_date": null, "expiry_date": "2040-12-21", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin efsitora alfa", "claim1_summary_ko": "Eli Lilly의 인슐린 에프시토라 알파 주 1회 기저 인슐린 Fc 융합체.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00072", "office": "USPTO", "pub_no": "US12189012B2", "app_no": "18/234,567", "title": "Once-weekly basal insulin Fc fusion analog efsitora alfa", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["A61K38/28"], "cpc": ["A61K38/28"], "priority_date": "2019-12-22", "app_date": "2020-12-21", "grant_date": "2025-01-14", "expiry_date": "2040-12-21", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "insulin efsitora alfa", "claim1_summary_ko": "Insulin efsitora alfa 미국 등록건.", "in_orange_book": true, "ob_use_code": "U-4123", "korean_filing": false},
  {"family_id": "F00073", "office": "USPTO", "pub_no": "US10456789B1", "app_no": "15/890,567", "title": "iLet bionic pancreas algorithm with automatic carb-free meal announcements", "assignee": "Beta Bionics, Inc.", "applicant_country": "US", "ipc": ["A61M5/172"], "cpc": ["A61M5/1723"], "priority_date": "2014-11-15", "app_date": "2015-11-14", "grant_date": "2019-10-29", "expiry_date": "2035-11-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "closed-loop", "drug_ref": "iLet Bionic Pancreas", "claim1_summary_ko": "Beta Bionics iLet 바이오닉 췌장 알고리즘으로 탄수화물 카운팅 없이 식사 알림만으로 동작.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00074", "office": "JPO", "pub_no": "JP7012890B2", "app_no": "2018-512789", "title": "セマグルチド経口錠剤の改良型製剤", "assignee": "ノボノルディスク エー/エス", "applicant_country": "DK", "ipc": ["A61K38/26", "A61K9/20"], "cpc": ["A61K38/26"], "priority_date": "2017-08-24", "app_date": "2018-08-23", "grant_date": "2022-05-19", "expiry_date": "2038-08-23", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "oral semaglutide", "claim1_summary_ko": "Oral semaglutide 일본 등록건.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00075", "office": "CNIPA", "pub_no": "CN114567890B", "app_no": "202011234567.8", "title": "新型口服GLP-1受体激动剂小分子化合物", "assignee": "中国医学科学院药物研究所", "applicant_country": "CN", "ipc": ["A61K31/4439"], "cpc": ["A61K31/4439"], "priority_date": "2019-11-08", "app_date": "2020-11-07", "grant_date": "2023-12-08", "expiry_date": "2040-11-07", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "GLP-1RA", "drug_ref": "CN-oral-GLP1", "claim1_summary_ko": "중국의학과학원의 신규 경구 GLP-1 수용체 작용제 소분자.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00076", "office": "USPTO", "pub_no": "US11890567B2", "app_no": "17/345,890", "title": "Smart contact lens with continuous glucose sensor", "assignee": "Google LLC", "applicant_country": "US", "ipc": ["A61B5/145", "G02C7/04"], "cpc": ["A61B5/14532"], "priority_date": "2019-08-12", "app_date": "2020-08-11", "grant_date": "2024-02-13", "expiry_date": "2040-08-11", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "CGM", "drug_ref": "Google smart lens", "claim1_summary_ko": "Google의 연속 혈당 센서 통합 스마트 콘택트렌즈.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00077", "office": "EPO", "pub_no": "EP3567890B1", "app_no": "17234567.9", "title": "Closed-loop artificial pancreas with model predictive control", "assignee": "Cambridge Enterprise Limited", "applicant_country": "GB", "ipc": ["A61M5/172", "G06N3/02"], "cpc": ["A61M5/1723"], "priority_date": "2015-12-18", "app_date": "2016-12-17", "grant_date": "2020-11-04", "expiry_date": "2036-12-17", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "closed-loop", "drug_ref": "CamAPS FX", "claim1_summary_ko": "Cambridge CamAPS FX 모델 예측 제어 기반 closed-loop 인공췌장.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00078", "office": "USPTO", "pub_no": "US12200345B2", "app_no": "18/345,123", "title": "Glucose-responsive smart insulin patch with microneedles", "assignee": "University of North Carolina at Chapel Hill", "applicant_country": "US", "ipc": ["A61K38/28", "A61M37/00"], "cpc": ["A61K38/28"], "priority_date": "2021-02-10", "app_date": "2022-02-09", "grant_date": "2025-02-04", "expiry_date": "2042-02-09", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin", "drug_ref": "UNC smart insulin patch", "claim1_summary_ko": "UNC의 혈당 반응성 마이크로니들 스마트 인슐린 패치.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00079", "office": "KIPO", "pub_no": "KR10-2712345A", "app_no": "10-2023-7034567", "title": "당뇨 환자 식이 자동 인식 AI 카메라 시스템", "assignee": "주식회사 카카오헬스케어", "applicant_country": "KR", "ipc": ["G16H20/60", "G06V20/00"], "cpc": ["G16H20/60"], "priority_date": "2022-08-15", "app_date": "2023-08-14", "grant_date": null, "expiry_date": "2043-08-14", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DTx", "drug_ref": "Kakao DM diet AI", "claim1_summary_ko": "카카오헬스케어의 당뇨환자 식이 자동 인식 AI 카메라 시스템(출원공개).", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00080", "office": "USPTO", "pub_no": "US11890890B2", "app_no": "17/567,890", "title": "Insulin pump infusion set with extended wear time", "assignee": "Medtronic MiniMed, Inc.", "applicant_country": "US", "ipc": ["A61M5/14"], "cpc": ["A61M5/14248"], "priority_date": "2020-05-18", "app_date": "2021-05-17", "grant_date": "2024-02-13", "expiry_date": "2041-05-17", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "insulin pump", "drug_ref": "Medtronic Extended Infusion Set", "claim1_summary_ko": "Medtronic의 인슐린 펌프 7일 연장 착용 인퓨전 세트.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00081", "office": "USPTO", "pub_no": "US10987890B2", "app_no": "16/345,567", "title": "Glucagon nasal spray Baqsimi rescue formulation", "assignee": "Eli Lilly and Company", "applicant_country": "US", "ipc": ["A61K38/26", "A61K9/00"], "cpc": ["A61K38/26"], "priority_date": "2014-08-22", "app_date": "2015-08-21", "grant_date": "2021-04-27", "expiry_date": "2035-08-21", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "glucagon", "drug_ref": "glucagon nasal (Baqsimi)", "claim1_summary_ko": "Baqsimi 비강 분무 글루카곤 저혈당 응급치료 제형.", "in_orange_book": true, "ob_use_code": "U-2789", "korean_filing": false},
  {"family_id": "F00082", "office": "KIPO", "pub_no": "KR10-2698012A", "app_no": "10-2023-7056789", "title": "AI 기반 당뇨병 합병증 예측 모델", "assignee": "주식회사 LG화학", "applicant_country": "KR", "ipc": ["G16H50/20", "G06N3/08"], "cpc": ["G16H50/20"], "priority_date": "2022-11-30", "app_date": "2023-11-29", "grant_date": null, "expiry_date": "2043-11-29", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "DTx", "drug_ref": "LG-DM-complication-AI", "claim1_summary_ko": "LG화학의 AI 기반 당뇨병 합병증 예측 모델(출원공개).", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00083", "office": "USPTO", "pub_no": "US12012890B2", "app_no": "17/789,012", "title": "VK2809 thyroid hormone receptor beta agonist for MASLD/T2D", "assignee": "Viking Therapeutics, Inc.", "applicant_country": "US", "ipc": ["A61K31/47"], "cpc": ["A61K31/47"], "priority_date": "2020-03-12", "app_date": "2021-03-11", "grant_date": "2024-05-21", "expiry_date": "2041-03-11", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "MASLD", "drug_ref": "VK2809", "claim1_summary_ko": "Viking Therapeutics VK2809 갑상선호르몬 수용체 베타 작용제 MASLD/T2D 치료용.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00084", "office": "USPTO", "pub_no": "US11567012B2", "app_no": "16/890,890", "title": "Vertex VX-880 stem cell-derived islet transplantation for T1D", "assignee": "Vertex Pharmaceuticals Incorporated", "applicant_country": "US", "ipc": ["A61K35/39"], "cpc": ["A61K35/39"], "priority_date": "2018-12-10", "app_date": "2019-12-09", "grant_date": "2023-01-31", "expiry_date": "2039-12-09", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "T1D-cell", "drug_ref": "VX-880", "claim1_summary_ko": "Vertex VX-880 줄기세포 유래 췌도세포 1형 당뇨병 이식치료.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false},
  {"family_id": "F00085", "office": "KIPO", "pub_no": "KR10-2723456A", "app_no": "10-2024-7012345", "title": "당뇨 환자용 GLP-1RA 자동 주사 디바이스", "assignee": "주식회사 메디센서", "applicant_country": "KR", "ipc": ["A61M5/24", "G16H20/17"], "cpc": ["A61M5/24"], "priority_date": "2023-03-22", "app_date": "2024-03-21", "grant_date": null, "expiry_date": "2044-03-21", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "smart pen", "drug_ref": "MediSensor GLP-1 pen", "claim1_summary_ko": "한국 스타트업 메디센서의 GLP-1RA 자동 주사 디바이스(출원공개).", "in_orange_book": false, "ob_use_code": null, "korean_filing": true},
  {"family_id": "F00086", "office": "USPTO", "pub_no": "US12245678B2", "app_no": "18/456,789", "title": "Vagal nerve stimulation device for type 2 diabetes", "assignee": "Enteromedics Inc.", "applicant_country": "US", "ipc": ["A61N1/36"], "cpc": ["A61N1/36007"], "priority_date": "2021-07-08", "app_date": "2022-07-07", "grant_date": "2025-03-04", "expiry_date": "2042-07-07", "pte_days": 0, "spc_extension_months": 0, "pediatric_extension": false, "category": "neurostim", "drug_ref": "vBloc DM", "claim1_summary_ko": "Enteromedics의 제2형 당뇨병용 미주신경 자극 디바이스.", "in_orange_book": false, "ob_use_code": null, "korean_filing": false}
]